Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.
Ishimoto U, Kinoshita A, Hirose Y, Shibata K, Ishii A, Shoji R, Yokota T, Iwaku A, Mizuno Y, Koike K, Saruta M. Ishimoto U, et al. Among authors: mizuno y. Cancer Chemother Pharmacol. 2019 Sep;84(3):647-654. doi: 10.1007/s00280-019-03895-2. Epub 2019 Jun 22. Cancer Chemother Pharmacol. 2019. PMID: 31230157
The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial.
Katano T, Shimura T, Nishie H, Iwai T, Itoh K, Ebi M, Mizuno Y, Togawa S, Shibata S, Yamada T, Mizushima T, Inagaki Y, Kitagawa M, Nojiri Y, Tanaka Y, Okamoto Y, Sugiura M, Matoya S, Nagura Y, Inagaki Y, Koguchi H, Ono S, Ozeki K, Hayashi N, Takiguchi S, Kataoka H. Katano T, et al. Among authors: mizuno y. J Gastroenterol. 2020 Sep;55(9):858-867. doi: 10.1007/s00535-020-01708-5. Epub 2020 Jul 15. J Gastroenterol. 2020. PMID: 32671536 Clinical Trial.
Long-term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction.
Nishie H, Shimura T, Katano T, Iwai T, Itoh K, Ebi M, Mizuno Y, Togawa S, Shibata S, Yamada T, Mizushima T, Inagaki Y, Kitagawa M, Nojiri Y, Tanaka Y, Okamoto Y, Matoya S, Nagura Y, Inagaki Y, Koguchi H, Ono S, Ozeki K, Hayashi N, Takiguchi S, Kataoka H. Nishie H, et al. Among authors: mizuno y. J Gastroenterol Hepatol. 2022 Jan;37(1):111-116. doi: 10.1111/jgh.15681. Epub 2021 Sep 21. J Gastroenterol Hepatol. 2022. PMID: 34478173 Clinical Trial.
Characteristic endoscopic findings of gastrointestinal malignant lymphomas other than mucosa-associated lymphoid tissue lymphoma.
Kanno T, Katano T, Shimura T, Nishigaki R, Kojima Y, Sasaki M, Okuda Y, Sugimura N, Fukusada S, Mizuno Y, Iwasaki H, Nishie H, Tanaka M, Ozeki K, Kubota E, Tanida S, Kataoka H. Kanno T, et al. Among authors: mizuno y. Acta Gastroenterol Belg. 2022 Jul-Sep;85(3):477-483. doi: 10.51821/85.3.9712. Epub 2022 Jun 21. Acta Gastroenterol Belg. 2022. PMID: 35770281 Free article.
A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer.
Kataoka H, Mori Y, Shimura T, Nishie H, Natsume M, Mochizuki H, Hirata Y, Sobue S, Mizushima T, Sano H, Mizuno Y, Nakamura M, Hirano A, Tsuchida K, Adachi K, Seno K, Kitagawa M, Kawai T, Joh T. Kataoka H, et al. Among authors: mizuno y. Cancer Chemother Pharmacol. 2016 May;77(5):957-62. doi: 10.1007/s00280-016-3013-y. Epub 2016 Mar 22. Cancer Chemother Pharmacol. 2016. PMID: 27002325 Clinical Trial.
2,524 results